Decreased Tumorigenesis and Mortality from Bladder Cancer in Mice Lacking Urothelial Androgen Receptor

作者: Jong-Wei Hsu , Iawen Hsu , Defeng Xu , Hiroshi Miyamoto , Liang Liang

DOI: 10.1016/J.AJPATH.2013.01.018

关键词: BiologyNeoplastic transformationUrotheliumCancer researchBladder cancerCarcinogenesisPathologyAndrogen receptorReceptorTransgeneProliferating cell nuclear antigenPathology and Forensic Medicine

摘要: Much fewer mice lacking androgen receptor (AR) in the entire body develop bladder cancer (BCa). However, role of urothelial AR (Uro-AR) BCa development remains unclear. In present study, we generated that lacked only Uro-AR (Uro-AR−/y) to by using carcinogen BBN [N-butyl-N-(4-hydroxybutyl)-nitrosamine] and found Uro-AR−/y had a lower incidence higher survival rate than did their wild-type (WT; Uro-AR+/y) littermates. In vitro assay also demonstrated facilitates neoplastic transformation normal cells carcinoma. IHC staining exhibited less DNA damage, with much expression p53 its downstream target protein PNCA WT urothelium, which suggests may modulate tumorigenesis through p53-PCNA repair signaling. Indeed, transgene, simian vacuolating virus 40 T (SV40T), urothelium (Uro-SV40T-AR−/y) similar as littermates (Uro-SV40T-AR+/y), was inactivated SV40T both genotypes. Use degradation enhancer ASC-J9 led suppression tumorigenesis, few adverse effects BBN-induced mouse model. Together, these results provide first direct in vivo evidence has an important promoting progression. Targeting novel approach suppress initiation.

参考文章(54)
John N. Eble, Liang Cheng, Michael O. Koch, Thomas M. Ulbright, Jiazhong Jiang, Cheryl Younger, David G. Bostwick, Katya Sanchez, Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Archives of Pathology & Laboratory Medicine. ,vol. 125, pp. 921- 923 ,(2001) , 10.5858/2001-125-0921-CACIPU
D Esrig, S Groshen, S C Chen, P W Nichols, R J Cote, P A Jones, D G Skinner, K Steven, B Chaiwun, C H Spruck rd, p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. American Journal of Pathology. ,vol. 143, pp. 1389- 1397 ,(1993)
Carmen Mir, Shahrokh F. Shariat, Theodorus H. van der Kwast, Raheela Ashfaq, Yair Lotan, Andrew Evans, Sean Skeldon, Sally Hanna, Rati Vajpeyi, Cynthia Kuk, Sultan Alkhateeb, Juan Morote, Bas W.G. van Rhijn, Peter Bostrom, Jorge Yao, Hiroshi Miyamoto, Michael Jewett, Neil Fleshner, Ed Messing, Alexandre R. Zlotta, Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study BJU International. ,vol. 108, pp. 24- 30 ,(2011) , 10.1111/J.1464-410X.2010.09834.X
Christine M. Chresta, John R. W. Masters, John A. Hickman, Hypersensitivity of Human Testicular Tumors to Etoposide-induced Apoptosis Is Associated with Functional p53 and a High Bax:Bcl-2 Ratio Cancer Research. ,vol. 56, pp. 1834- 1841 ,(1996)
Ming-Tse Sun, Hong-Yo Kang, Yi-Ju Chen, Kun-Ming Rau, Prognostic effects and regulation of activin A, maspin, and the androgen receptor in upper urinary tract urothelial carcinoma. Anticancer Research. ,vol. 31, pp. 1713- 1720 ,(2011)
F. F. Kadlubar, S. R. Tannenbaum, M. A. Butler, P. W. Skipper, D. W. Roberts, R. W. Benson, C. H. Teitel, J. R. Bailey, J. F. Young, K. L. Dooley, Frequency of Urination and Its Effects on Metabolism, Pharmacokinetics, Blood Hemoglobin Adduct Formation, and Liver and Urinary Bladder DNA Adduct Levels in Beagle Dogs Given the Carcinogen 4-Aminobiphenyl Cancer Research. ,vol. 51, pp. 4371- 4377 ,(1991)
G. F. Morris, J. R. Bischoff, M. B. Mathews, Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 895- 899 ,(1996) , 10.1073/PNAS.93.2.895
Yuting Lin, Ziyan Lu, John Kokontis, Jialing Xiang, Androgen receptor primes prostate cancer cells to apoptosis through down-regulation of basal p21 expression. Biochemical and Biophysical Research Communications. ,vol. 430, pp. 289- 293 ,(2013) , 10.1016/J.BBRC.2012.10.135
Eric C. Kauffman, Brian D. Robinson, Martin J. Downes, Leagh G. Powell, Ming Ming Lee, Douglas S. Scherr, Lorraine J. Gudas, Nigel P. Mongan, Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer Molecular Carcinogenesis. ,vol. 50, pp. 931- 944 ,(2011) , 10.1002/MC.20758